The Global Biomarkers Market Growth Accelerated By Increased Diagnostic Applications
![]() |
Biomarkers Market |
Biomarkers are indicators that help to detect specific
diseases or medical conditions such as cancer, heart disease and neurological
disorders. Biomarkers act as strong diagnostic tools by detecting a biological
state before actual clinical signs appear in the patient. Their ability to
detect diseases at an early stage increases patients' chances of full recovery
and cure.
The global biomarkers market is estimated to be valued at
US$ 17.97 Mn in 2024 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted
in a new report published by Coherent Market Insights.
Market key trends:
The increased usage of biomarkers in disease diagnosis has been a key trend
driving the growth of this market. Biomarkers help clinicians detect diseases
like cancer at an early stage when the chances of full recovery are higher. For
example, Cancer Antigen-125 (CA-125) is used to detect ovarian cancer,
prostate-specific antigen (PSA) for prostate cancer and carcinoembryonic
antigen (CEA) for colorectal, breast and lung cancers. Early detection allows
doctors to design and start treatment promptly, helping improve clinical
outcomes. Researchers are also working on identifying new biomarkers that can
detect diseases even before structural changes in organs occur. This will allow
predicting individuals at high risk of developing diseases and help prevent
illnesses, thereby further accelerating the demand for biomarkers.
Segment Analysis
The global biomarkers market is dominated by protein biomarkers sub segment
that accounts for more than 45% share of the total market. Protein biomarkers
are extensively employed in various disease diagnosis, staging, prognosis, and
personalized medicine for the treatment of diseases such as cancer,
neurological disorders, and cardiac disorders. The segment is expected to
retain its dominance over the forecast period owing to the increasing adoption
of protein biomarkers for various diagnostic applications and rising usage of
personalized medicine approach for tailored therapeutics.
Key Takeaways
The global
biomarkers market analysis is expected to witness high growth. The
global biomarkers market is estimated to be valued at US$ 17.97 Mn in 2024 and
is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030.
Regional analysis related content comprises North America
currently holds the largest share in the global biomarkers market owing to
rising prevalence of chronic diseases, increasing healthcare expenditure, and
presence of advanced healthcare facilities in the region. The Asia Pacific
region is expected to be the fastest growing market for biomarkers during the
forecast period attributed to rising geriatric population, increasing
prevalence of chronic and lifestyle diseases, growing healthcare expenditure,
and improving healthcare infrastructure in emerging economies.
Key players related content comprises Key players operating in the biomakers
market are Steris PLC, West Pharmaceutical Services Inc., Boston Analytical,
Intertek Pharmaceutical Services, Pace Analytical Services, Labcorp (Toxikon
Inc.), SGS SA, Eurofins Scientific, and Laboratory Testing Inc., among others.
Get more insights on this topic: https://www.newswirestats.com/biomarkers-market-industry-insights-trends-biomarkers-market/
Explore more information on this topic, Please visit:
https://www.urdughr.com/2023/12/ecoelegance-cellulose-plastics-the-green-alternative-to-traditional-petroleum-based-plastics.html
Comments
Post a Comment